OraSure Technologies, Inc. (OSUR) Conference Call Invitation  
7/5/2012 9:38:16 AM

BETHLEHEM, Pa., July 3, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that it will hold a conference call covering the recent U.S. Food and Drug Administration approval of the OraQuick® In-Home HIV Test and the Company's plans to commercialize this product, at 8:00 am ET (5:00 am PT) on Thursday, July 5, 2012. To participate in the conference call, dial 877-348-9357 (Domestic) or 970-315-0488 (International) and reference Conference ID #98134091.